Today's Veterinary Business

FEB 2019

Today’s Veterinary Business provides information and resources designed to help veterinarians and office management improve the financial performance of their practices, allowing them to increase the level of patient care and client service.

Issue link:

Contents of this Issue


Page 24 of 71

Overall clinical volume was up 2 percent compared with the fourth quarter of 2017, trailing the national average and down from the almost 5 percent growth observed in the third quarter. Canine and feline core vaccine volume growth were both sluggish in the fourth quarter, with canine volumes down more than 8 percent and feline more than 9 percent. For the second reporting period in a row, canine influenza utilization appeared to explode, up significantly from the fourth quarter of 2017 and far outpacing adoption rates on a national scale. Procedural volume showed above-average growth for the period, an improvement from several periods of significant decreased utilization. Flea and tick dose volume growth was again off from growth observed in the fourth quarter of 2017, slightly more significant than the effects observed nationally. Summary The Vetalytix Report utilizes change over time (growth/loss) as a foun- dation of the metrics reported each quarter. For the six reported cat- egories, a reader is able to ascertain the answer to a very important question: For each reported period, did the veterinary market in my geographic area experience growth or contraction compared with the same time prior year? Through 12 months of 2018, data revealed that the markets and market dynamics for veterinary medicine are very different, depending on what part of the country you're in. As a result, veterinary practices and the challenges they face are just as diverse. Data from the final quarter of 2018 appeared to confirm a slowing of clinical volumes through the veterinary channel as the year came to a close. In many regions that observed positive growth earlier in the year, the last quarter represented a change to the negative. Other categories, such as flea and tick dose volumes, continued to show challenges for the fourth quarter in a row, suggesting challenges that are more systemic to the ways these products are reaching our patients and customers. What will 2019 be like? It will be interesting to follow along. As high- lighted in each of the prior reports, some areas have significantly more challenges to face while others have positive dynamics to build off of in the new year. Understanding what these dynamics are, and how they may impact your business, can enable a practice to be more responsive to the unique needs of your marketplace. New England Q4 2018 Q4 2018 National Vet Consumption Index (Overall Clinical Volume) 2.0% 3.1% Canine Core Vacc Doses -8.3% -3.4% Canine Flu Vacc Doses 84.1% 27.2% Feline Core Vacc Doses -9.1% -3.8% Advanced Procedural Volume (Inhalant Anesth. Dynamics) 22.8% 12.8% Flea Tick Doses -19.8% -14.9% Vetalytix is the industry's largest repository of localized economic insight, regulatory compliance and pharmacy support tools, all of which are designed to help the private practitioner compete in today's challenging economy. Vetalytix is an open community available as a resource to the veterinary profession and is sponsored by the NAVC, Today's Veterinary Business and leading animal health distributors. For more detailed infor- mation related to your local market, go to You Only Sell Your Practice Once We'll Help You Maximize its Value Partner with Simmons and take advantage of our experience and proven systems to ensure a smooth transition for both seller and buyer. Our unparalleled expertise and resources have made us the leader in veterinary practice transition services nationwide. Secure your future by having the experts from Simmons on your side. Call 800.333.1984 or visit

Articles in this issue

Links on this page

Archives of this issue

view archives of Today's Veterinary Business - FEB 2019